Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;27(2):74-76.
doi: 10.1136/bmjebm-2020-111566. Epub 2020 Dec 10.

From publication bias to lost in information: why we need a central public portal for clinical trial data

Beate Wieseler  1 , Natalie McGauran  2
Affiliations

From publication bias to lost in information: why we need a central public portal for clinical trial data

Beate Wieseler et al. BMJ Evid Based Med. 2022 Apr.
No abstract available

Keywords: drug development; ethics; evidence-based practice; policy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: searching for studies. in: Higgins JPT, Green S. Cochrane Handbook for systematic reviews of interventions: version 5.1.0. Available: http://handbook.cochrane.org [Accessed 1 Sep 2020].
    1. Institute for Quality and Efficiency in Health Care . Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis (A16-70). Available: https://www.iqwig.de/en/projects-results/projects/drug-assessment/a16-70... [Accessed 1 Sep 2020].
    1. Janke K, Biester K, Krause D, et al. Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data. BMJ 2020;370:m2288. 10.1136/bmj.m2288 - DOI - PMC - PubMed
    1. Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010;14:iii, ix-xi, 1–193. 10.3310/hta14080 - DOI - PubMed
    1. Borysowski J, Wnukiewicz-Kozłowska A, Górski A. Legal regulations, ethical guidelines and recent policies to increase transparency of clinical trials. Br J Clin Pharmacol 2020;86:679–86. 10.1111/bcp.14223 - DOI - PMC - PubMed